Company Overview and News

27
My Top 5 Dividend Stocks For Young Investors: Revisited

2h seekingalpha
When I wrote the original piece a year ago, I picked AAPL, NVDA, NKE, DIS, and T.
V NKE AAPL MA MSFT SBUX NVDA

17
Under Armour: 6 Findings From Under The Hood In Q1

21h seekingalpha
“The first thing I do when I hear criticism is ask myself if they're right.” – Jeff Bezos (to Kevin Plank)
UA NKE UAA DKS KSS FL

14
My Starbucks Strategy-Combining Stocks And Options

22h seekingalpha
The stock market is a very demanding arena. As soon as you show a sign of weakness, you will be punished harshly.
NKE SBUX

47
Buying Dividend Growth Stocks Without Looking - More Than 3 Years Later.

2018-07-17 seekingalpha
The companies were purchased for their collective potential to deliver very solid total returns, but offering less volatility through a major market correction.
ABT LOW TXN WBA UTX CVS WMT MDT NKE JNJ CL MSFT QCOM MMM

25
U.S. Moats Back On Track

2018-07-17 seekingalpha
International moats outpaced the broad international market in June, but posted a loss on an absolute basis as international stocks continued to struggle. The Morningstar® Global ex-US Moat Focus IndexSM (MGEUMFUN, or "International Moat Index") led the MSCI All Country World Index ex-USA modestly in June (-1.65% vs. -1.88%, respectively). Domestic moat companies, as represented by the Morningstar® Wide Moat Focus IndexSM (MWMFTR, or "U.
FOX PAC CCV CMCSA RYCEY CCZ OMAB MORN 0694 NKE CCV.CL AMX RYCEF FOXA CMCSK DIS

7
Trade of the Day: Nike Inc (NKE) | InvestorPlace

2018-07-16 investorplace
To receive further updates on this Nike Inc (NYSE:NKE) trade as well as an alert when it’s time to take profits, sign up for a risk-free trial of SlingShot Trader today.
NKE

19
Nike Stays Put as Dow’s Top-Performing Stock

2018-07-14 247wallst
Athletic gear maker Nike Inc. (NYSE: NKE) tightened its hold as the top-performing Dow Jones industrials stock for the year to date. The shares added about 1.2% last week, following a gain of more than 13% combined in the prior two weeks. For the year to date, Nike stock is up 23.7%.
V NKE BOE MSFT BA UNH

97
March To Freedom Fund Mid-Year Review

2018-07-13 seekingalpha
The first half of 2018 is already over, so it is time to look back at how our portfolio performed, the purchases we made and to check our income growth.
SOJA LMT GIS XOM O.PRF TWX OPRF CVS ABT NKE HON AAPL ABBV DIS ABT VTR HON SO GILD O MA TWC RB CMI TGT V AFL PEP JNJ CVX DG MSFT SBUX ABBV QCOM

7
Online retail prompts bricks and mortar 'experience centre' revival

2018-07-13 theage.com.au
As online commerce spurs a race to the bottom on pricing of consumer goods, brand-name suppliers are deploying bricks and mortar to win over customers by pushing customer “experiences” over hard sell at lavishly designed outlets.
NKE

7
Online retail prompts bricks and mortar 'experience centre' revival

2018-07-13 smh.com.au
As online commerce spurs a race to the bottom on pricing of consumer goods, brand-name suppliers are deploying bricks and mortar to win over customers by pushing customer “experiences” over hard sell at lavishly designed outlets.
NKE

7
NKE / Nike, Inc. 8-K (Current Report)

2018-07-12 sec.gov
Document UNITED STATES
NKE

15
Can Traditional Retailers Survive the "Fast Fashion" Clothing Trend?

2018-07-12 zacks
It is no secret by now that consumers, especially millennials and younger generations, increasingly desire products that are more convenient, up-to-date with currents trends, and reasonably priced. That is especially evident in the fast-paced and dynamic fashion retail industry, as shown by “fast fashion” and its effects on the entire business.
JWN NKE URBN

9
Trade war may steer tax cuts' windfall to even more buybacks

2018-07-12 reuters
NEW YORK (Reuters) - The escalating trade war between the United States and China may prompt U.S. companies to shift money they had earmarked for capital expenditures into stock buybacks instead, pushing record levels of corporate share repurchases even higher.
NKE CSCO

7
Nike's CDO Is Working, But Investors Are Getting Ahead Of Themselves

2018-07-12 seekingalpha
The CDO has positively impacted the company's revenue growth. It currently stands close to 2015 levels.
NKE

22
Are U.S. Companies Investing Enough For The Future?

2018-07-12 seekingalpha
Corporate investments are the cornerstone of future growth. Yet shareholders are often seduced by buybacks and dividends. Equity investors should always make sure companies strike the right balance between deploying cash flows for short-term shareholder rewards and strategic reinvestment.
GE NKE

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to NKE / Nike, Inc. on message board site Silicon Investor.

Shipping - Oil u0026 Gas Tankers, Dry cargo, LNG NIKE NKE
The Justa and Lars Honors Bob Brinker Investment Club Thread Nike
Bob Brinker, Moneytalk and Marketimer LinkedIn Corporation
Nordic American Tankers (NAT) Humanists, atheists, agnostics, and other freethinkers! Are
A Bob Brinker Fan and Critic Club Bob Brinker: Market Savant u0026 Radio Host
CUSIP: 654106103